| 收费全文 | 1960936篇 |
| 免费 | 130728篇 |
| 国内免费 | 3171篇 |
| 耳鼻咽喉 | 28391篇 |
| 儿科学 | 65872篇 |
| 妇产科学 | 54962篇 |
| 基础医学 | 281443篇 |
| 口腔科学 | 53754篇 |
| 临床医学 | 169563篇 |
| 内科学 | 384848篇 |
| 皮肤病学 | 42292篇 |
| 神经病学 | 154254篇 |
| 特种医学 | 75500篇 |
| 外国民族医学 | 839篇 |
| 外科学 | 296185篇 |
| 综合类 | 39757篇 |
| 一般理论 | 510篇 |
| 预防医学 | 148511篇 |
| 眼科学 | 44207篇 |
| 药学 | 145979篇 |
| 45篇 | |
| 中国医学 | 3856篇 |
| 肿瘤学 | 104067篇 |
| 2018年 | 22233篇 |
| 2017年 | 16448篇 |
| 2016年 | 18063篇 |
| 2015年 | 20319篇 |
| 2014年 | 27337篇 |
| 2013年 | 41811篇 |
| 2012年 | 59635篇 |
| 2011年 | 62749篇 |
| 2010年 | 36206篇 |
| 2009年 | 33478篇 |
| 2008年 | 59322篇 |
| 2007年 | 63886篇 |
| 2006年 | 63641篇 |
| 2005年 | 62284篇 |
| 2004年 | 60141篇 |
| 2003年 | 57770篇 |
| 2002年 | 56457篇 |
| 2001年 | 86611篇 |
| 2000年 | 89340篇 |
| 1999年 | 76350篇 |
| 1998年 | 21331篇 |
| 1997年 | 19219篇 |
| 1996年 | 19513篇 |
| 1995年 | 18485篇 |
| 1994年 | 17483篇 |
| 1993年 | 16125篇 |
| 1992年 | 60825篇 |
| 1991年 | 59633篇 |
| 1990年 | 58361篇 |
| 1989年 | 56257篇 |
| 1988年 | 51983篇 |
| 1987年 | 50949篇 |
| 1986年 | 48288篇 |
| 1985年 | 46018篇 |
| 1984年 | 34544篇 |
| 1983年 | 29483篇 |
| 1982年 | 17608篇 |
| 1981年 | 15640篇 |
| 1979年 | 32001篇 |
| 1978年 | 22302篇 |
| 1977年 | 19234篇 |
| 1976年 | 18054篇 |
| 1975年 | 19735篇 |
| 1974年 | 23240篇 |
| 1973年 | 22409篇 |
| 1972年 | 21045篇 |
| 1971年 | 19272篇 |
| 1970年 | 18191篇 |
| 1969年 | 17146篇 |
| 1968年 | 15955篇 |
Purpose
The purpose of this study was to assess the potential of a deep learning model to discriminate between benign and malignant breast lesions using magnetic resonance imaging (MRI) and characterize different histological subtypes of breast lesions.Materials and methods
We developed a deep learning model that simultaneously learns to detect lesions and characterize them. We created a lesion-characterization model based on a single two-dimensional T1-weighted fat suppressed MR image obtained after intravenous administration of a gadolinium chelate selected by radiologists. The data included 335 MR images from 335 patients, representing 17 different histological subtypes of breast lesions grouped into four categories (mammary gland, benign lesions, invasive ductal carcinoma and other malignant lesions). Algorithm performance was evaluated on an independent test set of 168 MR images using weighted sums of the area under the curve (AUC) scores.Results
We obtained a cross-validation score of 0.817 weighted average receiver operating characteristic (ROC)-AUC on the training set computed as the mean of three-shuffle three-fold cross-validation. Our model reached a weighted mean AUC of 0.816 on the independent challenge test set.Conclusion
This study shows good performance of a supervised-attention model with deep learning for breast MRI. This method should be validated on a larger and independent cohort. 相似文献Aims
To obtain an overview of the management and outcomes of children aged 18 years or younger diagnosed with differentiated thyroid carcinoma of follicular cell origin across the UK, by collecting and analysing data from the limited number of centres treating these patients. This multicentre data might provide a more realistic perspective than single-institution series.Materials and methods
Six centres submitted data extracted from historical records on patients aged 18 years or younger, diagnosed between 1964 and 2017. The univariate and multivariable Cox proportional hazard model was used to identify potential predictors of progression-free survival, using national data as a control.Results
Data on 166 patients were available for analysis. Females (74%) were predominant, and the age ranged from 3 to 19 years at diagnosis, mean 14.1 years. Nodal metastases were present in 51%; 12% had distant metastases. After surgery, 95% received radioactive iodine (39% on more than one occasion) and 4% received external beam radiotherapy. With a median follow-up duration of 5 years, 69% are alive with no evidence of disease; 20% are alive with a raised thyroglobulin level as the only evidence of residual disease; 6% have residual structural disease detectable on imaging; 2% have died, from cerebral metastases.Conclusion
Despite most patients having advanced disease at presentation, outcomes are very good. A national prospective registry should allow systematic collection of good-quality data and may facilitate research to further improve outcomes. 相似文献- Download : Download high-res image (184KB)
- Download : Download full-size image
- Download : Download high-res image (267KB)
- Download : Download full-size image
Rotavirus (RV) is the most common cause of acute gastroenteritis in children <5 years of age worldwide, and vaccination reduces the disease burden. Evidence from postmarketing surveillance studies suggested an increased risk of intussusception (IS) in infants post-RV vaccination. An overall positive benefit–risk balance for the human RV vaccine (HRV) Rotarix (GlaxoSmithKline [GSK], Belgium) has been established and recent findings indicate an indirect effect of reduced IS over the long term.
ObjectiveThe aim of this study was to discuss spontaneous data from the GSK worldwide safety database on IS post-Rotarix administration.
MethodsThe database was reviewed for all spontaneous IS cases from 2004 to 2020. Additionally, an observed versus expected (O/E) analysis was done for adverse events attributed to IS. Data were reviewed as overall worldwide and stratified by region (Europe/USA/Japan) and dose.
ResultsA male predominance of IS patients was observed, consistent with earlier reports. The most frequently reported events in confirmed IS cases (Brighton Collaboration Working Group [BCWG] level 1) with time to onset ≤ 30 days post-vaccination were vomiting (55.8%), haematochezia (47.2%), and crying (21.1%). The observations from the IS spontaneous cases review and results of the O/E analysis are consistent with the known IS safety profile of RV vaccines: a transient increased incidence of IS post-vaccination (primarily in Europe/Japan/worldwide), mostly within 7 days postdose 1.
ConclusionSince the outcomes of early IS management are favourable over delayed management, healthcare professionals should inform parents about the importance of seeking immediate medical advice in case of unusual behaviour of the vaccinated infant. GSK continues to monitor the IS risk post-Rotarix administration through routine pharmacovigilance activities.
Graphic abstract